Michael S. Weiss, Chairman and CEO at KERYX BIOPHARMACEUTICALS INC (KERX), sold 80,000 shares at $18.32 ($1.5M) on 2006-03-21, disclosed to the SEC on 2006-03-23.
Scheduled sale ($1.5M) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.25 | 10,500 | $192K | 13.1% |
| 2 | $18.26 | 49,000 | $895K | 61.2% |
| 3 | $18.30 | 2,500 | $46K | 3.1% |
| 4 | $18.31 | 5,000 | $92K | 6.3% |
| 5 | $18.31 | 7,500 | $137K | 9.4% |
| 6 | $18.32 | 2,500 |
| $46K |
| 3.1% |
| 7 | $18.53 | 3,000 | $56K | 3.8% |
| Total | $18.28 avg | 80,000 | $1.5M | 100% |
| Filing → |
| FBIO | BUY | 2023-02-14 | $2.0M | — | Filing → |
| TGTX | SELL | 2022-01-07 | $2.6M | — | Filing → |
| TGTX | BUY | 2019-06-27 | $352K | — | Filing → |